Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Small Business Amendment Description Entity Emerging Growth Company Entity Filer Category Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Condensed Consolidated Balance Sheets Assets Current assets: Cash and cash equivalents Inventory Other current assets Total current assets [Assets, Current] Intangible assets, net Property and equipment, net Intangible Assets, Net Other assets Total assets [Assets] Liabilities And Stockholders' Equity (deficit) Current Liabilities: Notes payable Payables - related party Convertible notes payable Accrued expenses and others current liabilities Total current liabilities [Liabilities, Current] Long term liabilities: Convertible notes payable - noncurrent Operating lease liabilities - noncurrent Total long term liabilities Total liabilities [Liabilities] Stockholders' Equity (deficit) Preferred stock, $0.01 par value; 10,000,000 shares authorized; none issued Common stock, $0.01 par value; 300,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 144,379,308 shares issued and outstanding as of March 31, 2022 and December 31, 2021 Additional paid-in capital Operating Lease Liabilities- Non-current Accumulated deficit Translation adjustment Total stockholders' equity [Stockholders' Equity Attributable to Parent] Total liabilities and stockholders' equity [Liabilities and Equity] Preferred Stock, Par Value (in Dollars Per Share) Preferred Stock, Shares Authorized (in Shares) Preferred Stock, Shares Issued (in Shares) Preferred Stock, Shares Outstanding (in Shares) Common Stock, Par Value (in Dollars Per Share) Common Stock, Shares Authorized (in Shares) Common Stock, Shares Issued (in Shares) Common Stock, Shares Outstanding (in Shares) Condensed Consolidated Statements of Operations (Unaudited) Revenues Cost Of Revenues [Cost of Revenue] Gross Margin [Gross Profit] Operating Expenses: Research And Development Expenses Selling, General And Administrative Expenses Total Operating Expenses [Operating Expenses] Operating loss Non-operating income and expenses, net Interest expenses, net [Interest Expense] Other losses [Other Expenses] Total non-operating income and expenses, net Net loss Basic and diluted net loss per average share available to common shareholders Weighted average common shares outstanding- basic and diluted Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Net loss Other comprehensive loss: Translation adjustment [Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax] Comprehensive loss [Comprehensive Income (Loss), Net of Tax, Attributable to Parent] Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Statement [Table] Statement [Line Items] Equity Components [Axis] Common Stock Common Stock [Member] Preferred Stock Preferred Stock [Member] Additional Paid-In Capital Retained Earnings (Accumulated Deficit) Translation Adjustment [Translation Adjustment] Other comprehensive loss [Member] Balance, Amount Balance, Shares [Shares, Issued] Issuance Of Stock For Compensation, Shares Issuance Of Stock For Compensation, Amount Net loss Issuance Of Stock For Cash, Shares Share-based compensation Translation Adjustment [Translation Adjustment 1] Conversion Of Convertible Notes Into Common Stock, Shares Conversion Of Convertible Notes Into Common Stock, Amount Issuance Of Common Stock For Intangible Assets, Shares Issuance Of Stock For Options, Shares Acquisition Of Intangible Assets And Equipment [Payments to Acquire Intangible Assets] Balance, Amount Balance, Shares Condensed Consolidated Statements of Cash Flows (Unaudited) Cash flows from operating activities: Net Loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities: Depreciation And Amortization Share-based Compensation Expense Stock Issued For Compensation Share-based compensation expense Loss On Disposal Of Property, Plant And Equipment [Gain (Loss) on Disposition of Property Plant Equipment] Contract Liabilities Changes In Operating Assets And Liabilities: Inventory [Increase (Decrease) in Inventories] Other current assets [Increase (Decrease) in Other Current Assets] Accrued expenses and others current liabilities [Increase (Decrease) in Other Current Liabilities] Prepaid Expense And Other Current Assets [Increase (Decrease) in Prepaid Expense and Other Assets] Accounts Payable And Accrued Expenses Acquisition of property and equipment [Payments to Acquire Other Property, Plant, and Equipment] Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] Cash Flows From Investing Activities : Proceeds from convertible notes payable Patent Purchases [Patent Purchases] Proceeds from notes payable Acquisition Of Property, Plant And Equipment [Payments to Acquire Property, Plant, and Equipment] Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] Payments of other notes payable [Repayments of Notes Payable] Increase In Refundable Deposits And Others [Increase In Refundable Deposits And Others] Payments of lease liabilities Cash Flows From Financing Activities : Proceeds From Convertible Note Payable - Related Party Payments Of Other Note Payable Proceeds From Exercise Of Stock Options Payments Of Lease Liabilities Issuance of convertible notes for payables - related party Receivable of convertible notes issued Net change in equipment payable Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Effect from foreign currency exchange Net change in cash Cash And Cash Equivalents At Beginning Of Period Cash and cash equivalents at end of period Supplemental Disclosures Of Noncash Financing And Investing Activities: Cash Paid For Interest Stock Issued For Subscription Stock Issued For Patent Cost And Accrued Liabilities Conversion Of Convertible Notes And Accrued Interest Into Common Stock Rou Leased Assets Acquisition Of Intangible Assets And Equipment [Acquisition Of Intangible Assets And Equipment] Decrease Of Additional Paid In Capital Issuance Of Common Stock And Increase Of Current Liability Organization and Business. 1. Organization and Business Organization and Summary of Significant Accounting Policies Organization And Summary Of Significant Accounting Policies Basis of presentation 2. Basis of presentation Property, Equipment, net Property, Equipment And Software, Net Patents, net Patents, Net Convertible Notes Payable Convertible Notes Payable Debt Disclosure [Text Block] Financial Condition 3. Financial Condition Non-Current Convertible Notes Payable 7.Non-Current Convertible Notes Payable Related Party Transactions Related Party Transactions Related Party Transactions Disclosure [Text Block] Common Stock Common Stock Stockholders' Equity Note Disclosure [Text Block] Preferred Stock [Preferred Stock] Stock Option and Stock Plans Stock Option And Stock Plans 6.Current Convertible Notes Payable and Other Related Party Notes Payable Warrants Warrants [Warrants] Income Taxes Income Taxes Income Tax Disclosure [Text Block] Commitments and Contingencies Commitments And Contingencies Subsequent Events Subsequent Events Subsequent Events [Text Block] Organization And Business Basis Of Accounting Fair Value Of Financial Instruments Going Concern Stock-based Compensation Cash And Cash Equivalents Revenue Recognition Allowance For Doubtful Accounts Inventory Inventory, Policy [Policy Text Block] Property And Equipment Patents And Patent Expenditures Income Taxes Income Tax, Policy [Policy Text Block] Research And Development Use Of Estimates Basic And Diluted Net Income (loss) Per Share Concentration Of Credit Risk Recent Accounting Pronouncements Property, Equipment And Software Patents Estimated Future Amortization Expense Convertible Notes Payable Convertible Debt [Table Text Block] Convertible Notes Payable Deferred Tax Assets And Liabilities Equity Compensation Plan Information Schedule Of List Of Related Parties Plan Name [Axis] Upper [Member] Lower [Member] Recurring Losses Exceed Federally Insured Limit Insured Limit, Per Account Finite Lived Intangible Asset Use Ful Life Long-Lived Tangible Asset [Axis] Furniture and Equipment [Member] Machinery and Equipment [Member] Construction in Progress [Member] Property, Equipment, Gross Less: Accumulated Depreciation [Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment] Property, Equipment, Net Depreciation Expense Property, Equipment, Net Acquired Of Machinery And Equipment From Ainos Ky Pursuant Patents [Finite-Lived Intangible Assets, Gross] Less: Accumulated Amortization [Finite-Lived Intangible Assets, Accumulated Amortization] Patents, Net [Finite-Lived Intangible Assets, Net] 2022 2023 2024 2025 2026 Thereafter Total Expense Finite-Lived Intangible Assets by Major Class [Axis] Patents [Member] Amortization Expense Title of Individual [Axis] Related Party Transaction [Axis] Related Party [Axis] Dr. Stephen T. Chen [Member] 1.16 [Member] 2.16 [Member] 3.19 [Member] 4.19 [Member] 6.20 [Member] 7.20 [Member] 10.21 [Member] 11.21 [Member] Ainos KY [Member] 12.21 [Member] 13.21 [Member] 14.21 [Member] 15.21 [Member] 16.21 [Member] 17.21 [Member] 18.21 [Member] 19.21 [Member] 20.21 [Member] i2China Management Group LLC [Member] 5.19 [Member] 8a.20 [Member] 8b.20 [Member] 11.21 [Member] [11.21 [Member]] Total [Member] 21.21 [Member] 22.21[Member] 23.21[Member] 24.21[Member] 9.21 [Member] StephenChen i2 China 8b.20 [Member] [8b.20 [Member]] Total Convertible And Non-convertible Total Convertible And Non-convertible Addition Total Convertible And Non-convertible Payment Total Convertible And Non-convertible Accrued Accrued Interest Due Date Annual Interest Rate, From Effective Effective Date Unpaid Principal Balance Conversion Rate Payment Annual Interest Rate, Following Maturity Convertible Rate Addition Conversion Note Due Date [Due Date] Convertable Rate Payment [Payment] Convertible And Other Notes Payable- Related Parties [Convertible And Other Notes Payable- Related Parties] Payment Related Party Addition Related Party Accrued Interest Related Party Addition [Addition] Convertible And Other Notes Payable- Related Parties [Convertible And Other Notes Payable- Related Parties 1] Accrued Interest- Related Parties Payment [Payment 1] Accrued Interest [Accrued Interest] Annual Interest Rate Following Annual Interest Rate From,effective Convertable Rate [Convertable Rate] Effective Date [Effective Date] Addition [Addition 1] Notes Payable- Non-related Party Notes Payable- Non-related Accrued Total Notes Payable Total Notes Payable Addition Total Notes Payable Payment Total Notes Payable Accruel Convertible And Other Notes Payable- Related Parties Payment- Related Parties Dr. Stephen T Ainos KY [Member] Accrued Interest Total Convertible And Other Notes Payable Notes Payable For Related Parties Total Principal And Accrued Interest Amount Conversion Price Per Shares Interest Waived Repayment Of Debt Interest Expense Received Funding Dr. Stephen T. Chen [Member] ASE Technology Holding [Member] Ainos, Inc. (Cayman Island) [Member] Taiwan Carbon Nano Technology Corporation ("TCNT") [Member] Name Of The Related Party Relationship Description Non convertible notes payable Covid-19 Antigen Rapid Test Kits Principal amount Development expenses Purchase price accrued payable Convertible notes Total Assets Total Assets Percentage Capital Stock Holding Percentage Outstanding Capital Stock Percentage Common Stock Shares Issued Common Stock Shares Issued Price Per Share Common Stock Shares Authorized Issued And Outstanding Shares Of Common Stock Ownership Percentage Inventory [Inventory, Net] Product Development Expenses Account Payable Common Stock (Details Narrative)) Class of Stock [Axis] Counterparty Name [Axis] StephenChen Common Stocks [Member] Bernard Cohen [Member] Lawrence Lin [Member] John Junyong Lee [Member] Chen Agreement [Member] Ya-Ju [Member] Daniel Fisher [Member] Calibre Corporation [Member] i2China Management Group LLC [Member] [i2China Management Group LLC [Member]] Common Stock, Shares Outstanding And Reserved Reserved For Conversion Of Convertible Debt To Stock Future Exercise Of Stock Options Shares Reserved For Warrant Conversion Common Stock, Capital Shares Reserved For Future Issuance RSUs for non-employee directors Common Stock, Shares Authorized Common Stock, Shares, Issued, Total Shares Issued, Price Per Share Proceed From Issuance Of Common Stock Aggregate Principal And Accrued Interest Amount Preferred Stock, Shares Authorized Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Amarillo Biosciences, Inc., 2018 Employee Stock Option Plan Amarillo Biosciences, Inc., 2018 Officers, Directors, Employees, and Consultants Nonqualified Stock Option Plan Issue Date Range Total Shares Authorized Shares Issued Share Remaining Qualified Nonqualified Weighted Average Exercise Price Granted Weighted Average Exercise Price Exercised Weighted Average Exercise Price Expired Or Forfeited Weighted Average Exercise Price Outstanding, Ending [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Weighted Average Exercise Price Vested [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price] Weighted Average Remaining Contactual Term Outstanding Weighted Average Remaining Contactual Term Granted Weighted Average Remaining Contactual Term Vested Aggregate Intrinsic Value Outstanding, Ending [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value] Weighted Average Exercise Price Outstanding, Beginning Aggregate Intrinsic Value Granted Aggregate Intrinsic Value Exercised Aggregate Intrinsic Value Expired Or Forfeited Aggregate Intrinsic Value Vested [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value] Options Outstanding, Beginning [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number] Options Exercised Options Granted Options Expired Or Forfeited Options Outstanding, Ending Options Vested [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number] Award Type [Axis] Financial Instrument [Axis] 2018-ESOP Option [Member] 2018-NQSOP 2021 Employee Stock Purchase Plan Unrecognized Option Expense Unrecognized Option Expense Period Of Recognition Options To Acquire Shares Of Common Stock Volatility Rate Term Discount Percentage Stock Incentive Plan Description Number Of Shares Of Common Stock Issued Shares Price Per Shares Options Exercisable Term Period Vesting Period Vesting Percentage Warrants (Details Narrative) Measurement Input Type [Axis] Warrant [Member] Measurement Input, Price Volatility [Member] Measurement Input, Expected Term [Member] Measurement Input, Discount Rate [Member] Warrants, Volatility Warrant Exercise Price Number Of Warrant Purchase Common Stock Warrants Outstanding Warrants Outstanding, Term Warrants, Term Warrants, Discount Rate Provision (benefit) At Statutory Rate Permanent Differences Temporary Differences Change In Valuation Allowance Deferred Tax Assets: Net Operating Loss Carryforward Other Assets Deferred Tax Assets Deferred Tax Liabilities: Deferred Tax Liabilities [Deferred Tax Liabilities, Net] Net Deferred Tax Assets Valuation Allowance [Deferred Tax Assets, Valuation Allowance] Net Operating Loss Carryforwards U.s. Federal Income Tax, Rate Office Space Product Development Facility Area Contract Amount For Construction In Progress Outstanding Contract Amount For Construction In Progress Monthly Salary Monthly Salary Equivalent To Taiwan Dollors Annual Compensation In The Form Of Cash Percentage Range Vesting Stock Options Bonus Of Shares Warrants Issued Non-convertible Note Issued Principal Amount Converted Into Shares Of Common Stock Conversion Price Of Per Share Annual Salary Shares Payable Quarterly Based On The Average Share Price Principal And Accrued Interest Amount Covid-19 Antigen Rapid Test Kits Intellectual Property Assets Purchase Price Convertible Promissory Note Principal Amount Convertible Note Payable In Cash Date Initial Public Offering Price Of The Offering Percentage Unpaid Principal And Accrued Interest, And A Maturity Date Unpaid Principal And Accrued Interest Rate Non-convertible Note Issued Principal Amount Unpaid Principal Amount Accrued Interest i2China Management Group LLC [Member] 8b.20 [Member] 9.21 [Member] 26.22[Member] Total non-convertible notes payable Total non-convertible notes payable accrued interest Total non-convertible notes payable addition Total convertible and non-convertible Total convertible and non-convertible addition Total convertible and non-convertible Payment Total convertible and non-convertible accrued Non-convertible notes payable-related party Non-convertible notes payable-related party accrued interest Non-convertible notes payable-related party addition Accrued Interest Due Date Annual interest rate, From effective Effective Date Unpaid principal balance Conversion rate Payment Addition Conversion Note Annual interest rate, Following maturity consulting fee Convertible and other notes payable- related parties Accrued Interest- related parties Total interest expense Total Convertible and other notes payable Cumulative related accrued interest Principal amount Convertible notes Yun Han Liao [Member] Chih Heng Tsai [Member] Non-Current Convertible notes payable Conversion Price Per Shares Convertible Promissory Note Convertible note issued